Sichuan Huiyu Pharmaceutical Co Ltd Capital Reinvestment Ratio
Sichuan Huiyu Pharmaceutical Co Ltd capital reinvestment ratio. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥58.54 Million) in capital expenditures (CN¥30.63 Million). See Sichuan Huiyu Pharmaceutical Co Ltd (688553) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Capital reinvestment ratio of Sichuan Huiyu Pharmaceutical Co Ltd from 2018 to 2024. This chart tracks Sichuan Huiyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods. See Sichuan Huiyu Pharmaceutical Co Ltd (688553) flexibility index to measure the company's free cash flow as a share of total liabilities.
Sichuan Huiyu Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2018–2024)
Sichuan Huiyu Pharmaceutical Co Ltd capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Sichuan Huiyu Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | CN¥242.96 Million | CN¥128.18 Million | ▼ -88.1% |
| 2023 | 4.43x | CN¥66.93 Million | CN¥296.72 Million | ▲ +86.4% |
| 2022 | 2.38x | CN¥194.06 Million | CN¥461.61 Million | ▲ +145.0% |
| 2021 | 0.97x | CN¥446.36 Million | CN¥433.45 Million | ▲ +138.1% |
| 2020 | 0.41x | CN¥387.95 Million | CN¥158.24 Million | ▲ +21.0% |
| 2019 | 0.34x | CN¥326.22 Million | CN¥110.00 Million | ▲ +88.9% |
| 2018 | 0.18x | CN¥129.06 Million | CN¥23.04 Million | — |